Clinical evaluation of CENP-B and Scl-70 autoantibodies in silicosis patients
暂无分享,去创建一个
W. Fujimoto | H. Matsuzaki | T. Otsuki | Shoko Yamamoto | M. Kusaka | Y. Nishimura | Suni Lee | K. Yoshitome | H. Hayashi | T. Hatayama | N. Kumagai-Takei | K. Uragami | Miho Ikeda | M. Ikeda
[1] H. Matsuzaki,et al. Environmental factors and human health: fibrous and particulate substance-induced immunological disorders and construction of a health-promoting living environment , 2016, Environmental Health and Preventive Medicine.
[2] A. Fazaa,et al. Association of pulmonary silicosis and systemic sclerosis , 2015, BMJ Case Reports.
[3] Ying Chen,et al. Silica exposure and altered regulation of autoimmunity , 2014, Environmental Health and Preventive Medicine.
[4] N. Amft,et al. Systemic lupus erythematosus complicating simple silicosis. , 2014, Occupational medicine.
[5] Y. Shoenfeld,et al. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects. , 2013, Journal of autoimmunity.
[6] Y. Shoenfeld,et al. Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld’s syndrome): clinical and immunological spectrum , 2013, Expert review of clinical immunology.
[7] W. Fujimoto,et al. Environmental factors producing autoimmune dysregulation--chronic activation of T cells caused by silica exposure. , 2012, Immunobiology.
[8] T. Otsuki,et al. Dysregulation of the immune system caused by silica and asbestos , 2010, Journal of immunotoxicology.
[9] S. Murakami,et al. Reductive Alteration of the Regulatory Function of the CD4+CD25+ T Cell Fraction in Silicosis Patients , 2010, International journal of immunopathology and pharmacology.
[10] S. Murakami,et al. Soluble Interleukin-2 Receptor as an Indicator of Immunological Disturbance Found in Silicosis Patients , 2009, International journal of immunopathology and pharmacology.
[11] T. Nakano,et al. Immunological effects of silica and asbestos. , 2007, Cellular & molecular immunology.
[12] D Rees,et al. Silica, silicosis and tuberculosis. , 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[13] H. Nishimura,et al. Silica-associated systemic lupus erythematosus in an elderly man. , 2007, Internal medicine.
[14] A. Ueki,et al. Alterations of Fas and Fas-Related Molecules in Patients with Silicosis , 2006, Experimental biology and medicine.
[15] H. Sakaguchi,et al. Reduced Function of CD4+25+ Regulatory T Cell Fraction in Silicosis Patients , 2006, International journal of immunopathology and pharmacology.
[16] W. Fujimoto,et al. Detection, epitope‐mapping and function of anti‐Fas autoantibody in patients with silicosis , 2005, Immunology.
[17] W. Rom,et al. Basic pathogenetic mechanisms in silicosis: current understanding , 2005, Current opinion in pulmonary medicine.
[18] J. Reveille,et al. Anti-scl-70 , 2005, Autoimmunity.
[19] T. Saeki,et al. Two cases of hypertrophic pachymeningitis associated with myeloperoxidase antineutrophil cytoplasmic autoantibody (MPO-ANCA)-positive pulmonary silicosis in tunnel workers , 2004, Clinical Rheumatology.
[20] P. Itin,et al. Arthritis and interstitial granulomatous dermatitis (Ackerman syndrome) with pulmonary silicosis. , 2003, Seminars in arthritis and rheumatism.
[21] Y. Isozaki,et al. Intramolecular epitope spreading among anti‐caspase‐8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals , 2002, Clinical and experimental immunology.
[22] H. Sakaguchi,et al. Autoantibodies detectable in the sera of silicosis patients. The relationship between the anti-topoisomerase I antibody response and HLA-DQB1*0402 allele in Japanese silicosis patients. , 2001, The Science of the total environment.
[23] A. Ueki,et al. Antidesmoglein Autoantibodies in Silicosis Patients with No Bullous Diseases , 2001, Dermatology.
[24] H. Sakaguchi,et al. Is the anti-topoisomerase I autoantibody response associated with a distinct amino acid sequence in the HLA-DQbeta1 domain? , 2001, Arthritis and rheumatism.
[25] H. Sakaguchi,et al. Different distribution of HLA class II alleles in anti-topoisomerase I autoantibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain. , 2001, Immunobiology.
[26] H. Sakaguchi,et al. Reduced Expression of the Inhibitory Genes for Fas‐Mediated Apoptosis in Silicosis Patients , 2000 .
[27] H. Sakaguchi,et al. Detection of alternatively spliced variant messages of Fas gene and mutational screening of Fas and Fas ligand coding regions in peripheral blood mononuclear cells derived from silicosis patients. , 2000, Immunology letters.
[28] Otsuki,et al. Over‐expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients , 2000, Clinical and experimental immunology.
[29] H. Sakaguchi,et al. Evaluation of cases with silicosis using the parameters related to Fas-mediated apoptosis. , 1999, International journal of molecular medicine.
[30] G. Cooper,et al. Occupational exposure to crystalline silica and autoimmune disease. , 1999, Environmental health perspectives.
[31] C. Kallenberg,et al. Silicon exposure and vasculitis. , 1998, Current opinion in rheumatology.
[32] Y. Isozaki,et al. Elevated soluble Fas/APO‐1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours , 1997, Clinical and experimental immunology.
[33] K. Steenland,et al. Silica exposure and autoimmune diseases. , 1995, American journal of industrial medicine.
[34] T. Dragani,et al. Libri Ricevuti: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1992 .
[35] C. Kallenberg,et al. Early detection of connective tissue disease in patients with Raynaud's phenomenon. , 1990, Rheumatic diseases clinics of North America.
[36] P. Hessel,et al. Silica, silicosis, and progressive systemic sclerosis. , 1985, British journal of industrial medicine.
[37] R. A. McReynolds,et al. Immunotoxicology of silica. , 1982, Critical reviews in toxicology.
[38] K. Constantinidis. Pneumoconiosis and Rheumatoid arthritis (Caplan's syndrome). , 1977, The British journal of clinical practice.
[39] T. Benedek. Rheumatoid pneumoconiosis. Documentation of onset and pathogenic considerations. , 1973, The American journal of medicine.
[40] P. Elmes,et al. International classification of radiographs of pneumoconioses. , 1971, British journal of industrial medicine.
[41] T. Medsger,et al. The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis. , 1967, Annals of internal medicine.
[42] A. Caplan. Rheumatoid Disease and Pneumoconiosis (Caplan's Syndrome) , 1959, Proceedings of the Royal Society of Medicine.